Drug
Pxvx0200
Pxvx0200: highest development phase Phase 3, developed by Emergent BioSolutions. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| PXVX0200 NCT02100631 | Phase 3 | Cholera |
| PXVX0200 NCT01585181 | Phase 1 | Cholera |
Latest
No recent events.
Follow Pxvx0200 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.